Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.59B | 9.62B | 7.11B | 6.32B | 5.59B | 4.72B | Gross Profit |
3.27B | 3.45B | 2.58B | 2.26B | 1.97B | 1.66B | EBIT |
648.38M | 596.39M | 661.33M | 365.54M | 301.57M | 39.64M | EBITDA |
1.17B | 596.39M | 971.97M | 981.09M | 831.92M | 579.22M | Net Income Common Stockholders |
269.37M | 251.22M | 313.84M | 435.05M | 405.58M | 164.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
308.00M | 240.57M | 295.34M | 145.38M | 182.04M | 152.66M | Total Assets |
11.90B | 11.99B | 12.49B | 6.67B | 5.05B | 5.18B | Total Debt |
4.90B | 4.74B | 4.94B | 2.22B | 802.02M | 1.15B | Net Debt |
4.59B | 4.50B | 4.65B | 2.08B | 619.98M | 992.46M | Total Liabilities |
7.86B | 7.95B | 8.35B | 3.97B | 2.43B | 2.88B | Stockholders Equity |
4.03B | 4.04B | 4.14B | 2.70B | 2.62B | 2.30B |
Cash Flow | Free Cash Flow | ||||
482.45M | 428.73M | 497.48M | 460.70M | 365.10M | 336.28M | Operating Cash Flow |
715.77M | 667.49M | 678.01M | 600.72M | 514.18M | 507.61M | Investing Cash Flow |
-234.99M | -244.27M | -2.11B | -1.84B | -78.65M | -109.22M | Financing Cash Flow |
-404.68M | -492.53M | 1.80B | 1.24B | -401.87M | -335.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $39.66B | 16.62 | 16.61% | 1.57% | 4.09% | 14.05% | |
76 Outperform | $3.65B | 13.85 | 6.34% | 2.41% | 21.67% | -17.91% | |
75 Outperform | $7.51B | 14.61 | 22.21% | 1.58% | 7.31% | -15.86% | |
75 Outperform | $2.77B | 15.37 | 21.21% | ― | -0.64% | 30.96% | |
66 Neutral | $2.26B | 14.71 | 8.65% | ― | -8.05% | -18.60% | |
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% | |
46 Neutral | $2.89B | 7.39 | 12.88% | ― | -5.65% | 78.20% |
On June 3, 2025, Olivier Duha resigned from the Board of Directors of Concentrix Corporation, effective immediately. His resignation was due to personal reasons and not because of any disagreements with the company’s operations, policies, or practices.
The most recent analyst rating on (CNXC) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Concentrix stock, see the CNXC Stock Forecast page.